Squarer Ron
Insider CIK 1454001 · ARRY Chief Executive Officer, Director · RTRX Director · DCPH Director · ADCT Director · NUVL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 4,418 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-15 | 6,281 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2026-06-16 | 2026-06-18 | 3,444 | — | $0 | 6,281 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2026-06-03 | 2026-06-03 | 15,196 | $3.08 | $46.8K | 123,431 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2026-06-01 | 2026-06-03 | 45,000 | — | $0 | 138,627 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 39,375 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2025-12-10 | 2025-12-11 | 4,418 | — | $0 | 4,418 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2025-12-10 | 2025-12-11 | 2,837 | — | $0 | 2,837 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2025-06-13 | 2025-06-17 | 15,184 | $3.58 | $54.4K | 93,627 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2025-06-03 | 2025-06-05 | 40,000 | — | $0 | 108,811 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 35,375 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2024-06-17 | 2024-06-18 | 6,995 | $2.89 | $20.2K | 80,663 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2024-06-13 | 2024-06-14 | 40,000 | — | $0 | 87,658 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 3,269 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 30,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 4,727 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 18,500 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 9,570 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 28,875 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 22,375 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 17,875 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 14,875 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-01-15 | 2021-01-20 | 1,563 | $31.99 | $50.0K | 1,563 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 11,875 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-12-04 | 2020-02-20 | 21,900 | — | $0 | 21,900 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-12-04 | 2019-12-06 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 453,750 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 421,875 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 545,820 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 345,312 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 600,000 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 113,438 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer deriv | 2019-07-30 | 2019-07-30 | 678,750 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 442,190 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | D To issuer | 2019-07-30 | 2019-07-30 | 259,891 | $48.00 | $12.47M | 442,190 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 8,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 18,906 | — | $0 | 18,907 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-04-01 | 2019-04-03 | 18,907 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2019-04-01 | 2019-04-03 | 16,631 | $24.60 | $409.1K | 259,891 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-04-01 | 2019-04-03 | 37,813 | — | $0 | 276,522 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-02-07 | 2019-02-08 | 110,000 | — | $0 | 545,820 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-02-07 | 2019-02-08 | 110,000 | $21.64 | $2.38M | 238,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-02-07 | 2019-02-08 | 110,000 | $3.61 | $397.1K | 348,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-31 | 2019-02-01 | 113,438 | — | $0 | 113,438 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-01-31 | 2019-02-01 | 113,438 | $18.53 | $2.10M | 238,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-31 | 2019-02-01 | 113,438 | $7.30 | $828.1K | 352,147 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2019-01-30 | 2019-02-01 | 100,000 | — | $0 | 655,820 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2019-01-30 | 2019-02-01 | 100,000 | $3.61 | $361.0K | 338,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2019-01-30 | 2019-02-01 | 100,000 | $18.25 | $1.82M | 238,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 23,437 | — | $0 | 46,876 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-12-16 | 2018-12-18 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-12-16 | 2018-12-18 | 21,303 | $15.97 | $340.2K | 238,709 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-12-16 | 2018-12-18 | 48,437 | — | $0 | 260,012 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 113,125 | — | $0 | 113,125 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2018-12-14 | 2018-12-18 | 678,750 | — | $0 | 678,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-27 | 2018-06-29 | 140,625 | — | $0 | 421,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-06-27 | 2018-06-29 | 77,881 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-06-27 | 2018-06-29 | 140,625 | $18.03 | $2.54M | 211,575 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-27 | 2018-06-29 | 140,625 | $8.79 | $1.24M | 352,200 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2018-06-27 | 2018-06-29 | 43,628 | $17.74 | $774.0K | 211,575 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-06-27 | 2018-06-29 | 77,881 | — | $0 | 289,456 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-06-27 | 2018-06-29 | 34,253 | $18.50 | $633.7K | 255,203 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 6,875 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2018-04-01 | 2018-04-03 | 18,906 | — | $0 | 37,813 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2018-04-01 | 2018-04-03 | 16,605 | $16.32 | $271.0K | 211,575 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2018-04-01 | 2018-04-03 | 18,906 | — | $0 | 228,180 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-19 | 2017-12-19 | 333,165 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-19 | 2017-12-19 | 79,688 | — | $0 | 345,312 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-19 | 2017-12-19 | 133,380 | — | $0 | 755,820 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-19 | 2017-12-19 | 133,380 | $3.61 | $481.5K | 342,654 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-19 | 2017-12-19 | 79,688 | $4.63 | $369.0K | 422,342 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-19 | 2017-12-19 | 333,165 | $5.94 | $1.98M | 755,507 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2017-12-19 | 2017-12-19 | 546,233 | $10.93 | $5.97M | 209,274 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 226,874 | — | $0 | 226,876 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 16,835 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-18 | 2017-12-19 | 110,800 | — | $0 | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 226,874 | $7.30 | $1.66M | 355,077 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2017-12-18 | 2017-12-19 | 273,438 | $10.73 | $2.93M | 209,274 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 110,800 | $3.61 | $400.0K | 482,712 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-18 | 2017-12-19 | 16,835 | $5.94 | $100.0K | 371,912 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-12-16 | 2017-12-19 | 23,437 | — | $0 | 70,313 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2017-12-16 | 2017-12-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-12-16 | 2017-12-19 | 10,917 | $10.92 | $119.2K | 128,203 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-12-16 | 2017-12-19 | 23,437 | — | $0 | 139,120 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-04-10 | 2017-04-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-04-10 | 2017-04-12 | 4,375 | — | $0 | 4,375 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2017-04-01 | 2017-04-04 | 18,906 | — | $0 | 56,719 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-04 | 12,042 | $8.94 | $107.7K | 114,327 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2017-04-01 | 2017-04-04 | 18,906 | — | $0 | 126,369 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2017-04-01 | 2017-04-06 | 17,563 | $8.94 | $157.0K | 115,683 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 562,500 | — | $0 | 562,500 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-12-27 | 2016-12-29 | 93,750 | — | $0 | 93,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 75,625 | — | $0 | 75,625 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2016-04-01 | 2016-04-05 | 453,750 | — | $0 | 453,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2016-04-01 | 2016-04-05 | 5,878 | $3.00 | $17.6K | 107,463 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2015-04-01 | 2015-04-03 | 453,750 | — | $0 | 453,750 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2015-04-01 | 2015-04-03 | 75,625 | — | $0 | 108,166 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2015-03-02 | 2015-03-04 | 40,000 | $8.25 | $330.0K | 12,927 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-04 | 77,881 | — | $0 | 77,881 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise deriv | 2015-03-01 | 2015-03-24 | 77,881 | — | $0 | 77,881 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | M Exercise | 2015-03-01 | 2015-03-04 | 77,881 | $7.96 | $619.9K | 77,881 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | F Tax w/h | 2015-03-01 | 2015-03-04 | 24,954 | $7.96 | $198.6K | 52,927 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-08-18 | 2014-08-20 | 155,762 | — | $0 | 155,762 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2014-04-01 | 2014-04-03 | 425,000 | — | $0 | 425,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2013-05-03 | 2013-05-07 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award | 2012-10-04 | 2012-10-05 | 4,397 | — | $0 | 4,397 | SEC↗ |